Wally Health Raises $25 Million: Can a $249 Dental Membership Disrupt Dental Insurance and the DSO Model?
Dentistry has spent decades arguing about PPOs, DSOs, private equity, hygiene shortages, overtreatment, undertreatment, artificial intelligence and why so many patients still avoid the dentist. Wally Health has managed to bundle nearly all of those debates into one company.
Wally is betting that a large piece of dentistry can be separated from the traditional dental office and rebuilt around a simple consumer proposition: pay $249 a year, skip dental insurance, receive unlimited preventive cleanings and diagnostics, and use technology to make the experience faster, more comfortable and more predictable.
Investors are taking the idea seriously. On October 7, 2026, Wally announced a $25 million Series A led by Maveron, with participation from Bling Capital and angel investors including Jack Abraham, cofounder of Hims. Wally also announced a strategic partnership with EMS Dental. The company says it has more than 50,000 members at 15 locations and plans to reach 100 locations by the end of 2027. If Wally can pull that off economically, dentists should pay attention.
What Exactly Is Wally? Wally was founded in 2020 by Tyler Burnett, who serves as cofounder and CEO, Stipe Latkovic, cofounder and CTO, and Chelsea Patel, cofounder and Head of Experience. Its pitch is intentionally provocative. Burnett argues that traditional dentistry operates in an insurance system that often rewards procedures after disease develops rather than prevention before disease develops. Wally wants to reverse that equation.
Its $249 annual membership includes unlimited preventive cleanings, exams, X rays, 3D scans and whitening without traditional dental insurance. Wally also offers additional services including periodontal therapy, Curodont for selected early caries lesions, clear aligners, retainers and nightguards.
What Wally generally does not provide is equally important. It is not trying to be a full service restorative dental practice performing crowns, implants, root canals and every other procedure under one roof. Patients who need more extensive restorative care are referred elsewhere.
That makes Wally different from the traditional DSO model. It is attempting to own the preventive relationship while deliberately referring much of the expensive restorative complexity out of the system.
There is also a legal distinction worth noting. Wally’s own terms describe Wally Health as a software platform supporting healthcare providers rather than the entity directly providing dental care. In dental industry language, people may call it a DSO, but structurally it appears closer to a management and technology platform supporting affiliated clinical providers.
Why Consumers Might Want This. Wally did not invent America’s dental access problem. Only about 40 percent of working age American adults receive dental care in a given year. Utilization is dramatically higher among people with private dental benefits than among uninsured patients. Patients complain about cost, confusing benefits, unpredictable bills, inconvenient appointments and uncomfortable treatment. Then Wally walks in and says, “$249 for the year.” That message is not difficult to understand.
Burnett’s own origin story reinforces the company’s positioning. After moving from Canada to the United States, he says a dentist told him he needed eight fillings. Burnett sought additional opinions and says he subsequently learned that seven were unnecessary. Around the same time, he was dating the woman who became his wife, a recent dental school graduate. That experience helped convince him that dentistry’s economic incentives needed to change. It is a terrific startup story. It is not evidence that American dentists routinely overtreat patients. One disputed treatment plan is an anecdote, not epidemiology.
Changing the Incentive. Wally likes to criticize a system in which dentistry can “profit off decay.” There is a legitimate argument buried inside the slogan. Fee for service healthcare creates incentives around billable procedures, and dental insurance reimbursement can absolutely influence practice economics. But Wally has not eliminated financial incentives. It has changed them.
The company collects recurring membership revenue and can generate additional revenue from periodontal therapy, Curodont, aligners, nightguards and other services. There is nothing inherently wrong with that. Every healthcare organization has incentives. The important question is whether clinical recommendations remain appropriate when those recommendations generate revenue.
Some online reviewers have complained that they joined for “unlimited cleanings” only to be told they needed periodontal treatment at additional cost. Those complaints do not prove inappropriate diagnosis. A patient with periodontal disease should not receive a prophylaxis simply because the marketing department used the word unlimited. But it demonstrates an important tension. “Unlimited cleanings” is simple. Periodontal diagnosis is not.
AIRFLOW Is Interesting, But It Is Not Magic. Wally relies heavily on EMS AIRFLOW and Guided Biofilm Therapy instead of traditional metal instrumentation for much of its hygiene care. There is legitimate science behind the technology. Randomized clinical trials suggest Guided Biofilm Therapy can produce comparable clinical outcomes while improving patient comfort and reducing treatment time. Some studies have found treatment time reductions ranging from roughly 9 percent to approximately 25 percent, depending on the patient population and protocol. That matters because shorter appointments are not merely a patient experience advantage. They may be central to Wally’s economics.
If a hygienist can safely deliver excellent care in substantially less chair time, a $249 unlimited membership becomes much easier to understand financially. But evidence that AIRFLOW can improve comfort and efficiency is not the same thing as proving that every Wally appointment is “pain-free” or completed in half the time. Marketing likes absolutes. Science generally does not.
What About “Reversing Cavities”? Wally also promotes Curodont for selected early carious lesions. Curodont is based on a self assembling peptide known as P11 4. Published clinical evidence suggests that it may help arrest or reduce certain initial, noncavitated carious lesions. A systematic review found encouraging results but also noted elevated risk of bias among the included trials and called for longer term research. Subsequent randomized clinical research has also reported favorable outcomes. That makes Curodont interesting. It does not mean dentistry has eliminated the bur.
Statements suggesting patients can simply say goodbye to drilling forever go beyond what the evidence currently supports. A better clinical description is that some appropriately selected early lesions may be arrested or improved using noninvasive remineralization strategies before conventional restorative treatment becomes necessary. That is still exciting without turning it into magic.
The $249 Question. This is where dentists start doing math. Wally reports more than 50,000 members. If all 50,000 are active members paying $249 annually, that represents approximately $12.45 million in annual membership revenue. Wally says the average member visits approximately three times per year. That would represent roughly 150,000 visits annually. Divide $12.45 million by 150,000 visits and the membership generates approximately $83 per visit before any additional revenue. That is not profit. It is simply arithmetic.
Wally still has to pay hygienists, dentists, payroll expenses, equipment, supplies, EMS consumables, rent, technology, marketing, customer acquisition, administration and corporate overhead. Hygienists in Wally markets can earn roughly $55 to $60 an hour. If a visit requires 30 minutes of hygiene labor, direct hygienist wages alone could approach $30 before benefits and payroll burden. The business can still work. But the economics probably require some combination of high throughput, inexpensive real estate, strong annual renewals, efficient staffing and additional revenue from services beyond the $249 membership.
We simply do not know from publicly available information whether the membership is highly profitable, approximately break-even, or intentionally priced as a customer acquisition tool. That is probably the single most important unanswered business question.
The Real Estate Strategy. One of Wally’s smartest ideas may have nothing to do with AI. Instead of constructing traditional standalone dental offices, Wally has placed studios inside coworking environments and other unconventional locations. Burnett says the company can establish locations for a fraction of the cost of a traditional dental practice because Wally requires less equipment, less space and less complicated construction. If true, that changes the expansion equation dramatically. A traditional dental office is an expensive little machine. Compress the service mix, standardize the equipment and remove much of restorative dentistry, and suddenly you may be able to create a much smaller clinical footprint. Wally is essentially asking whether preventive dentistry can become retail.
The AI Question. Wally also says its proprietary AI platform manages scheduling and operations while helping guide clinicians through appointments. That may create real efficiencies, but the public information does not yet tell us how much of Wally’s operating advantage comes from artificial intelligence versus good software, standardized protocols and centralized management. Dentistry is currently living through an era in which every algorithm seems to require an AI nametag. The relevant question is much simpler. Does the technology lower cost, improve diagnosis, increase access, reduce errors or make clinicians more productive? If it does, dentists should care what it accomplishes more than what the marketing department calls it.
The 97 Percent Number. Wally reports a 97 percent hygienist retention rate. In today’s hygiene labor market, that statistic is almost enough to make a practice owner choke on his coffee. It is also difficult to evaluate without more information. Retention over what period? How many hygienists? Are part time clinicians included? How is turnover calculated?
If Wally truly maintains 97 percent hygienist retention using consistent definitions over meaningful periods, that may be one of the company’s greatest competitive advantages. Modern technology, limited restorative chaos, standardized protocols and a different workplace experience could plausibly improve clinician retention. I would simply like to see the denominator.
What Patients Say. Online reviews present two dramatically different versions of Wally. Trustpilot shows predominantly favorable reviews. Patients frequently praise the clinicians, modern technology, comfortable cleanings, convenience and value. At the other extreme, the Better Business Bureau contains a small number of very unhappy customers reporting billing, cancellation, scheduling and customer service problems. Neither source represents a scientific sample. Happy patients who are encouraged to leave reviews can skew one direction. Angry consumers who specifically seek out the BBB can skew dramatically in the other.
The useful signal is repetition. Across multiple platforms, recurring complaints involve appointment availability, difficulty reaching a human, billing or cancellation friction, additional periodontal charges and concerns about privacy in open treatment environments. Those complaints deserve attention. They do not establish that Wally is unsafe, unethical or fraudulent.
Scaling Is the Real Test. Wally’s goal of expanding from 15 locations to 100 by the end of 2027 is where this experiment becomes truly interesting. That requires adding 85 locations in a little more than a year. Healthcare does not scale like software. Every new market requires licensed clinicians, recruiting, training, equipment, quality control, real estate, patient acquisition and enough utilization to support the location.
The $25 million Series A works out to roughly $294,000 for each of those 85 planned locations if you perform the intentionally simplistic exercise of dividing the entire investment by 85. Obviously Wally can use existing revenue, financing, additional capital and numerous other funding sources. But the calculation illustrates something important. The low cost clinic model is not a cute feature. It is essential to the strategy.
Do Not Underestimate Wally. Dentists should resist dismissing Wally simply because its marketing occasionally pokes traditional dentistry in the eye. There is a legitimate business innovation here. Preventive care is relatively standardized. Consumers dislike unpredictable bills. Insurance creates administrative friction. Hygienists are scarce. Traditional offices are expensive to build. Patients increasingly expect transparent pricing, mobile scheduling and consumer grade experiences. Wally combines recurring revenue, standardized workflows, AIRFLOW, digital diagnostics, centralized technology, smaller real estate footprints and a narrow clinical menu. Then it refers much of the restorative complexity elsewhere. That is a coherent model.
Sophisticated venture investors putting $25 million behind the company does not prove it will succeed. Venture capital has financed plenty of beautiful disasters. But investors typically see financial and operational information the public does not. The investment suggests there is probably more traction underneath the hood than a clever website and aggressive marketing.
What I Would Ask Tyler Burnett. I would not waste much time asking whether patients like paying $249 for preventive dentistry. Of course they do. I would ask how many of the reported 50,000 members are currently active and paying. I would want the 12 month and 24 month renewal rates, customer acquisition cost, customer lifetime value, member contribution margin and average revenue per member beyond the basic membership.
I would want to know how much revenue comes from periodontal therapy, Curodont, orthodontics, nightguards and other additional services. I would ask for the distribution of annual visits rather than simply the average.
Clinically, I would want to know what percentage of members are diagnosed with periodontal treatment, what percentage receive Curodont and how the organization audits diagnostic consistency.
Operationally, I would want appointment wait times, cancellation rates, refunds, clinician turnover measured over clearly defined periods and location level profitability.
Those numbers would tell us whether Wally is reinventing preventive dentistry or using venture capital to subsidize an irresistible consumer offer.
Maybe It Is Part of the Future. Wally has clearly identified genuine consumer demand and created a differentiated preventive experience. It has attracted serious investors and developed an unusually asset-light model for dental delivery. What we do not yet know is whether $249 unlimited preventive care produces attractive standalone economics, whether its reported clinician retention survives rapid expansion, or whether the patient experience remains consistent when 15 locations become 100.
Dentists should ignore both extremes. Do not automatically believe slogans about traditional dentistry profiting from decay, painless cleanings in half the time or never needing another drill. But do not read several furious online reviews and decide Wally is a scam either. The more interesting reality sits between those positions.
Wally is a credible, well funded and unusually ambitious attempt to unbundle prevention from traditional dentistry and rebuild it as a national consumer subscription business. The question is no longer whether patients want it. The question is whether the economics, clinical model and customer experience still work when 15 locations become 100. If Wally proves that preventive dentistry can be more convenient, affordable and profitable at national scale, should traditional dental practices copy it, compete with it or partner with it?
Join the Conversation!